Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-928-3 | CAS number: 68630-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- The detailed method followed in this study is described in XCellR8 SOP L0069: ‘EpiOcularTM Eye Irritation Test (OECD TG492) and is based on the MatTek protocol (MK-24-007-0055, 10 Feb 17) using the MatTek Corporation EpiOcularTM reconstructed tissue model OCL-200. This protocol was approved as the new OECD TG492 at the 2015 meeting of the OECD Working Group of the National Coordinators for the Test Guidelines Programme
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Sodium 2-heptyl-2,3-dihydro-3-(2-hydroxyethyl)-1H-imidazole-1-propionate
- EC Number:
- 271-928-3
- EC Name:
- Sodium 2-heptyl-2,3-dihydro-3-(2-hydroxyethyl)-1H-imidazole-1-propionate
- Cas Number:
- 68630-95-5
- Molecular formula:
- C15H28N2O3.Na
- IUPAC Name:
- sodium 3-[2-heptyl-3-(2-hydroxyethyl)-2,3-dihydro-1H-imidazol-1-yl]propanoate
- Test material form:
- solid
- Details on test material:
- Product name: Crodateric CYAP
Batch Number: PS-196-555
Appearance: The sample has been produced from drying of the aqueous solution of the material as sold commercially. It is observed to be a brown sticky solid
Constituent 1
- Specific details on test material used for the study:
- Supplier Croda
Test Item Name Crodateric CYAP-100
Supplier Code DEV080817DS3
Supplier batch/lot number PS-196-562
CAS number 70983-43-6
Purity 99.41% (from Sponsor Certificate of Analysis)
Expiry Date 3 July 2018
Physical state Solid, Dark, Brown
Storage Conditions Room Temperature
Solubility N/A - neat application
Administration method Topical application
Concentration tested Neat
XCellR8 test item code CRO1026
Study test item code TA1
Test animals / tissue source
- Species:
- human
- Strain:
- other: reconstructed tissue. MatTek’s EpiOcularTM system consists of normal, human-derived keratinocytes which have been cultured to form a stratified, squamous epithelium similar to that found in the cornea.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- After pre-wetting tissues with 20µl PBS (Sterile Dulbecco’s Phosphate Buffered Saline) for 30 ± 2 min, single topical application of nominal 50mg of neat test item, using a pin applicator or 50µl of reference items to the surface of the EpiOcularTM model for 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion, and 18 hours ± 15 minutes’ post-treatment incubation, prior to the MTT endpoint; three tissues per condition (n=3).
- Duration of treatment / exposure:
- After pre-wetting tissues with 20µl PBS (Sterile Dulbecco’s Phosphate Buffered Saline) for 30 ± 2 min, single topical application of nominal 50mg of neat test item, using a pin applicator or 50µl of reference items to the surface of the EpiOcularTM model for 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion, and 18 hours ± 15 minutes’ post-treatment incubation, prior to the MTT endpoint; three tissues per condition (n=3).
- Details on study design:
- The EpiOcularTM tissue model (OCL-200-MatTek Corporation) is composed of stratified human keratinocytes in a three-dimensional structure, reflecting the morphology and function of the human corneal epithelium found in vivo.
The EpiOcular™ Eye Irritation Test (EIT), using the MatTek EpiOcularTM tissue model OCL-200, was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe between 2008 and 2013. From this validation study and its independent peer review it was concluded that the EpiOcularTM EIT is able to correctly identify chemicals (both substances and mixtures) not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS, and the test method was recommended as scientifically valid for that purpose, as an alternative to Draize Rabbit Eye Test with excellent correlation -In vivo to In vitro test results.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: percentage of viability
- Run / experiment:
- The test item Crodateric CYAP-100 did not reduce the viability to 60% or below after 6h of application and should be considered as non-Irritant to the eye.
- Value:
- 97.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- Prior to the study, the required compatibility checks (as per SOP L0069) show that the test item did interfere with MTT. However, OD obtained with the freeze-killed tissues were low (<0.1) and therefore they were not subtracted from OD values obtained during the main assay.
Any other information on results incl. tables
Mean and SD of viability measurements and of viability percentages after 6h (± 15 min) of application and 18h (± 15 min) post-incubation.
Name |
Code |
mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
Sterile water |
NC |
1.421 |
0.068 |
100.0 |
4.8 |
4.8 |
Non-Irritant |
Methyl Acetate |
PC |
0.035 |
0.025 |
2.4 |
1.7 |
71.6 |
Irritant |
CRODATERIC CYAP-100 |
TA1 |
1.383 |
0.098 |
97.3 |
6.9 |
7.1 |
Non-Irritant |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Interpretation of Results following Prediction Model
• A test item is considered to be irritant to the eye (i.e. would require labelling as either GHS 1 or 2) if the eye model viability after exposure and post-treatment incubation is ≤60%.
• A test item is considered as a non-irritant to the eye (i.e. would not require a warning label in the European chemical classification systems) if the eye model viability after exposure and post-treatment incubation is >60%.
The current assay is not intended to differentiate between GHS class 1 and GHS class 2 or R36 and R41 (degree of stromal damage).
The percentage of viability obtained with test item Crodateric CYAP-100 was 97.3%, therefore it has to be considered as Non- Irritant to the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.